Research Analysts Set Expectations for AMETEK Q3 Earnings

Key Points

• Zacks Research raised AMETEK’s Q3 2026 EPS estimate to $2.11 from $2.08 and maintained a “Strong Buy” rating. Its forecasts call for $8.40 EPS in FY2026, $9.58 in FY2027 and $10.66 in FY2028.
• Analyst sentiment remains positive overall, with AMETEK holding a consensus “Moderate Buy” rating and an average price target of $267. Several firms recently increased their targets, including KeyCorp to $295 and BNP Paribas Exane to $290.
• AMETEK recently exceeded quarterly expectations, reporting $2.09 EPS and $2.04 billion in revenue, up 15% year over year. Shares opened at $247.67, while the company maintains a $0.34 quarterly dividend, representing a 0.5% yield.

AMETEK, Inc. (NYSE:AME - Free Report) - Equities researchers at Zacks Research increased their Q3 2026 earnings per share (EPS) estimates for AMETEK in a report released on Wednesday, October 7th. Zacks Research analyst Team now anticipates that the technology company will earn $2.11 per share for the quarter, up from their previous estimate of $2.08. Zacks Research currently has a "Strong-Buy" rating on the stock. The consensus estimate for AMETEK's current full-year earnings is $8.42 per share. Zacks Research also issued estimates for AMETEK's Q4 2026 earnings at $2.23 EPS, FY2026 earnings at $8.40 EPS, Q1 2027 earnings at $2.23 EPS, Q2 2027 earnings at $2.32 EPS, Q3 2027 earnings at $2.46 EPS, Q4 2027 earnings at $2.57 EPS, FY2027 earnings at $9.58 EPS, Q1 2028 earnings at $2.64 EPS, Q2 2028 earnings at $2.65 EPS, Q3 2028 earnings at $2.66 EPS and FY2028 earnings at $10.66 EPS.

Other equities research analysts also recently issued research reports about the stock. Robert W. Baird increased their target price on shares of AMETEK from $275.00 to $280.00 and gave the stock a "neutral" rating in a research note on Monday. Citigroup boosted their price target on AMETEK from $257.00 to $261.00 and gave the company a "neutral" rating in a research report on Wednesday, August 5th. BNP Paribas Exane increased their price objective on AMETEK from $280.00 to $290.00 and gave the stock an "outperform" rating in a research report on Friday, September 11th. KeyCorp lifted their target price on AMETEK from $260.00 to $295.00 and gave the company an "overweight" rating in a research note on Wednesday, August 5th. Finally, Morgan Stanley boosted their target price on AMETEK from $235.00 to $245.00 and gave the company an "equal weight" rating in a report on Friday, July 10th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $267.00.

AMETEK Trading Down 0.4%

Shares of AMETEK stock opened at $247.67 on Friday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.76 and a current ratio of 1.21. The company has a market capitalization of $56.77 billion, a P/E ratio of 36.21, a PEG ratio of 2.35 and a beta of 0.96. AMETEK has a 1 year low of $179.24 and a 1 year high of $261.16. The company's fifty day moving average is $244.70 and its two-hundred day moving average is $235.40.

AMETEK (NYSE:AME - Get Free Report) last announced its earnings results on Tuesday, August 4th. The technology company reported $2.09 EPS for the quarter, beating analysts' consensus estimates of $1.99 by $0.10. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. The business had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $1.95 billion. During the same period in the previous year, the company posted $1.78 EPS. The company's quarterly revenue was up 15.0% on a year-over-year basis. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS.

AMETEK Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, September 15th. This represents a $1.36 annualized dividend and a yield of 0.5%. AMETEK's payout ratio is currently 19.88%.

Insider Buying and Selling

In other AMETEK news, insider David Hermance sold 6,608 shares of the business's stock in a transaction on Friday, August 7th. The stock was sold at an average price of $254.00, for a total transaction of $1,678,432.00. Following the sale, the insider directly owned 42,509 shares in the company, valued at approximately $10,797,286. The trade was a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.54% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Frazier Financial Advisors LLC acquired a new stake in AMETEK in the 2nd quarter valued at about $25,000. Fiduciary Financial Advisors purchased a new stake in shares of AMETEK in the second quarter valued at about $27,000. Elevation Wealth Partners LLC lifted its holdings in shares of AMETEK by 239.5% in the second quarter. Elevation Wealth Partners LLC now owns 129 shares of the technology company's stock valued at $31,000 after purchasing an additional 91 shares in the last quarter. MV Capital Management Inc. acquired a new stake in shares of AMETEK in the fourth quarter valued at approximately $28,000. Finally, Brown Lisle Cummings Inc. increased its stake in shares of AMETEK by 878.6% during the 1st quarter. Brown Lisle Cummings Inc. now owns 137 shares of the technology company's stock worth $29,000 after purchasing an additional 123 shares in the last quarter. Institutional investors and hedge funds own 87.43% of the company's stock.

More AMETEK News

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Zacks Research upgraded AMETEK to “Strong Buy” from “Hold,” adding a positive signal for investor sentiment. AMETEK Upgraded to Strong-Buy at Zacks Research
• Positive Sentiment: Zacks raised EPS forecasts across 2026-2028. Estimates increased to $8.40 for FY2026, $9.58 for FY2027 and $10.66 for FY2028, compared with previous forecasts of $8.27, $8.74 and $9.33, respectively. Quarterly estimates were also lifted, including Q3 2026 EPS to $2.11 from $2.08. The revisions imply improving expectations for AMETEK’s earnings growth and are well above the current-year consensus of $8.42 by FY2028.
• Positive Sentiment: Near-term earnings expectations remain constructive. Zacks said AMETEK’s history of earnings surprises and current operating factors could position it to exceed estimates again in its upcoming quarterly report. Why AMETEK Could Beat Earnings Estimates Again
• Positive Sentiment: Baird raised its price target to $280 from $275, indicating additional upside based on its assessment of AMETEK’s prospects. Baird Raises AMETEK Price Target
• Neutral Sentiment: AMETEK recently reported strong quarterly execution, including earnings above consensus and 15% year-over-year revenue growth. Those results support the bullish revisions, but the shares already reflect considerable optimism, with a P/E ratio above 36.

About AMETEK

AMETEK, Inc NYSE: AME is a global manufacturer of industrial technology products. The company develops and produces electronic instruments and electromechanical devices used in process, industrial, aerospace, power, energy, and other specialized markets.

AMETEK's Electronic Instruments segment supplies products such as process and analytical instruments, measurement and testing equipment, power-quality monitoring systems, automation and control solutions, and equipment for aerospace and defense applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.